J. Ashley Jefferson

7.5k total citations · 3 hit papers
50 papers, 5.2k citations indexed

About

J. Ashley Jefferson is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J. Ashley Jefferson has authored 50 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Nephrology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in J. Ashley Jefferson's work include Renal Diseases and Glomerulopathies (27 papers), Chronic Kidney Disease and Diabetes (8 papers) and Renal and Vascular Pathologies (6 papers). J. Ashley Jefferson is often cited by papers focused on Renal Diseases and Glomerulopathies (27 papers), Chronic Kidney Disease and Diabetes (8 papers) and Renal and Vascular Pathologies (6 papers). J. Ashley Jefferson collaborates with scholars based in United States, United Kingdom and Canada. J. Ashley Jefferson's co-authors include Richard J. Johnson, Stuart J. Shankland, Jeremy Hughes, Katherine Gordon, Duk‐Hee Kang, Marilda Mazzali, Yoon-Goo Kim, Duvuru Geetha, Hui Y. Lan and Salah D. Kivlighn and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Hepatology.

In The Last Decade

J. Ashley Jefferson

48 papers receiving 5.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

VEGF Inhibition and Renal Thrombotic Microangiopathy

2008 1.1k citations J. Ashley Jefferson, Charles E. Alpers et al. profile →
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism

2001 1.0k citations Marilda Mazzali, Jeremy Hughes et al. profile →
ANCA-Associated Vasculitis: Core Curriculum 2020

2019 252 citations J. Ashley Jefferson et al. American Journal of Kidney Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Ashley Jefferson United States	27	2.7k	1.6k	1.1k	861	673	50	5.2k
Udo Helmchen Germany	37	2.1k 0.8×	1.1k 0.7×	942 0.8×	711 0.8×	565 0.8×	110	4.8k
Tammo Ostendorf Germany	44	2.0k 0.7×	2.0k 1.2×	651 0.6×	382 0.4×	645 1.0×	98	5.1k
Heather N. Reich Canada	43	3.8k 1.4×	786 0.5×	843 0.8×	1.0k 1.2×	485 0.7×	143	5.9k
Atsushi Shioi Japan	36	2.2k 0.8×	1.5k 0.9×	648 0.6×	623 0.7×	773 1.1×	97	5.3k
Diane Proudfoot United Kingdom	28	2.2k 0.8×	1.1k 0.7×	701 0.6×	465 0.5×	707 1.1×	39	4.8k
Catherine Meyer‐Schwesinger Germany	37	2.2k 0.8×	1.3k 0.8×	640 0.6×	678 0.8×	312 0.5×	93	4.6k
Kengo Furuichi Japan	41	2.2k 0.8×	1.3k 0.8×	701 0.6×	416 0.5×	703 1.0×	179	5.6k
Chunsun Dai China	52	2.8k 1.0×	4.1k 2.6×	962 0.9×	744 0.9×	1.2k 1.8×	119	8.0k
Changli Wei United States	27	2.9k 1.1×	1.2k 0.8×	493 0.4×	663 0.8×	313 0.5×	61	4.2k
Mauro Abbate Italy	48	3.0k 1.1×	2.3k 1.4×	890 0.8×	681 0.8×	1.6k 2.3×	116	7.2k

Countries citing papers authored by J. Ashley Jefferson

Since Specialization

Citations

This map shows the geographic impact of J. Ashley Jefferson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ashley Jefferson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ashley Jefferson more than expected).

Fields of papers citing papers by J. Ashley Jefferson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ashley Jefferson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ashley Jefferson. The network helps show where J. Ashley Jefferson may publish in the future.

Co-authorship network of co-authors of J. Ashley Jefferson

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ashley Jefferson. A scholar is included among the top collaborators of J. Ashley Jefferson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ashley Jefferson. J. Ashley Jefferson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ahmad, Syeda B. & J. Ashley Jefferson. (2025). Targeting B Cells and Plasma Cells in Glomerular Disease. Journal of the American Society of Nephrology. 36(9). 1844–1857. 1 indexed citations

2.

Jefferson, J. Ashley, Karin Chen, Sangeeta Hingorani, et al.. (2025). Genetic and Iatrogenic Defects in Peripheral Tolerance Associated with Anti-Nephrin Antibody-Associated Minimal Change Disease. PubMed. 5(1). 74–83.

3.

Baird, Geoffrey S., Bessie A. Young, Michael J. Ryan, et al.. (2021). Calculating estimated glomerular filtration rate without the race correction factor: Observations at a large academic medical system. Clinica Chimica Acta. 520. 16–22. 16 indexed citations

4.

Jefferson, J. Ashley, et al.. (2021). Steroid Minimization in Adults with Minimal Change Disease. PubMed. 1(4). 237–249. 1 indexed citations

5.

Andeen, Nicole K., J. Ashley Jefferson, Shreeram Akilesh, et al.. (2018). IgA-dominant glomerulonephritis with a membranoproliferative pattern of injury. Human Pathology. 81. 272–280. 14 indexed citations

6.

Easterling, Thomas R., et al.. (2017). Nephrotic syndrome in pregnancy poses risks with both maternal and fetal complications. Kidney International. 91(6). 1464–1472. 32 indexed citations

7.

Jefferson, J. Ashley, Charles E. Alpers, & Stuart J. Shankland. (2011). Podocyte Biology for the Bedside. American Journal of Kidney Diseases. 58(5). 835–845. 55 indexed citations

8.

Jefferson, J. Ashley, Jeffrey W. Pippin, & Stuart J. Shankland. (2010). Experimental models of membranous nephropathy. Drug Discovery Today Disease Models. 7(1-2). 27–33. 43 indexed citations

9.

Jefferson, J. Ashley, Jane M. Simoni, Elizabeth Escudero, et al.. (2004). Increased Oxidative Stress Following Acute and Chronic High Altitude Exposure. High Altitude Medicine & Biology. 5(1). 61–69. 137 indexed citations

10.

Courtney, Aisling E., et al.. (2004). Acute Polymyositis Following Renal Transplantation. American Journal of Transplantation. 4(7). 1204–1207. 5 indexed citations

11.

Tietz, P., et al.. (2003). 476 Isolation and characterization of specialized microdomains of hepatocyte plasma membranes: Potential role in canalicular bile formation. Hepatology. 38. 389–389. 1 indexed citations

12.

Mazzali, Marilda, et al.. (2003). Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney International. 63(6). 2088–2093. 68 indexed citations

13.

Jefferson, J. Ashley, Elizabeth Escudero, Abdías Hurtado, et al.. (2002). Excessive erythrocytosis, chronic mountain sickness, and serum cobalt levels. The Lancet. 359(9304). 407–408. 61 indexed citations

14.

Suga, Shin-ichi, Yoon-Goo Kim, Alison Joly, et al.. (2001). Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney International. 60(4). 1297–1308. 64 indexed citations

15.

Kang, Duk‐Hee, Sharon Anderson, Yoon-Goo Kim, et al.. (2001). Impaired angiogenesis in the aging kidney: Vascular endothelial growth factor and Thrombospondin-1 in renal disease. American Journal of Kidney Diseases. 37(3). 601–611. 229 indexed citations

16.

Heidet, Laurence, Erika Timmer, B.J.C. van den Bosch, et al.. (2000). Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney International. 58(5). 1870–1875. 104 indexed citations

17.

Kim, Yoon-Goo, Shin-ichi Suga, Duk‐Hee Kang, et al.. (2000). Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney International. 58(6). 2390–2399. 181 indexed citations

18.

Heidet, Laurence, Erika Timmer, B.J.C. van den Bosch, et al.. (2000). Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney International. 58(5). 1870–1875. 1 indexed citations

19.

Savage, J. M., et al.. (1999). Improved prognosis for congenital nephrotic syndrome of the Finnish type in Irish families. Archives of Disease in Childhood. 80(5). 466–469. 14 indexed citations

20.

Jefferson, J. Ashley, et al.. (1997). Autosomal dominant Alport syndrome linked to the type IV collagen alpha3 and alpha4 genes. Nephrology Dialysis Transplantation. 1595–1599. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact